Major Insider Move Signals Growing Confidence in Outlook TherapeuticsTip Ranks·8 hours agoOTLK+10.62%
Outlook Therapeutics director Faisal Ghiath Sukhtian acquires 95,398 common shares for $99,962.34PUBT·15 hours agoOTLK+10.62%
US Biotech Sector Nears Commercialization Inflection Point on Key FDA ApprovalsGlobal Report·1 day ago, 04:19 AMCRSP+0.19%GENB-0.46%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·1 day ago, 07:05 AMALT-2.34%OTLK+10.62%
Pre-market hot trades in US stocks: Outlook Therapeutics pre-market down 8.99%; Advanced Semiconductor Engineering pre-market down 7.52%Price Alert·1 day ago, 06:18 AMOTLK+10.62%ASX-8.28%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·2 days ago, 12:06 PMMPLT+22.01%PFSA-4.71%
Oncobiologics (NASDAQ:OTLK) Stock Price Expected to Rise, HC Wainwright Analyst SaysMarket Beat·2 days ago, 12:00 PMOTLK+10.62%GS-D-5.00%
Outlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejectionbenzinga_article·2 days ago, 09:13 AMOTLK+10.62%
This General Motors Analyst Turns Bulish; Here Are Top 5 Upgrades For Mondaybenzinga_article·2 days ago, 06:23 AMF-C-0.36%F-D-0.28%
Pre-market hot trades in US stocks: Outlook Therapeutics up 8.84% in pre-market; SAP up 4.80% in pre-marketPrice Alert·Jul 27 at 05:08 AMOTLK+10.62%SAP+3.81%
FDA Approvals and Earnings Beats Propel Specialized US-Listed FirmsGlobal Report·Jul 26 at 04:14 AMREPL+1.12%CELC+0.97%
Niche U.S. Equities Face Commercial and Regulatory Tests in Mid-2026Global Report·Jul 25 at 04:18 AMAUR-3.70%VSME-0.81%
From Web3 Pivots to AI Robotics Deals: Tracking Capital Shakeups Across U.S. EquitiesGlobal Report·Jul 25 at 04:13 AMOTLK+10.62%YYAI-67.65%
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD | OTLK Stock NewsStockTitan·Jul 24 at 05:40 AMOTLK+10.62%
